Specialties:

Most Popular Reports:

Newest Reports:

Drug Eluting Stents: Trends in Use

A Survey of Sixty Interventional Cardiologists

January 2008

Deliverable: Survey with key findings.

Study Description:

Topic

Drug Eluting Stent Usage

Respondent Type

Physicians

Specialties Covered

Interventional Cardiology

Region

United States and Europe

Methodology

Online survey, self-administered via a Panel Intelligence website

Duration: 20 minutes

Size: 60 respondents

Fielding Dates: January 3, 2008 to January 8, 2008

Objectives:

To understand trends in the use of drug eluting stents.  Specifically to:

§    Determine the current use of drug eluting stents (DESs) in various patient types and lesion types.

·     Investigate anticipated impact of COURAGE trial results on DES usage.

·     Identify drivers of potential increases or decreases in use over the next two years.

§    Rank the importance of safety concerns regarding DESs.

§    Rank various factors in terms of their influence on DES product selection.

§    Evaluate DES products on these factors.

§    Determine effect of published data on possible uptake of Custom NX product, XTENT.

§    Compare and contrast responses between physicians from the United States and Europe.

Companies and Products Mentioned in This Report: 

Company

Ticker Symbol

Product(s)

Boston Scientific

BSX

Taxus

Abbott

ABT

Xience

Medtronic

MDT

Endeavor

Cordis (Wyeth)

N/A

Cypher

Inclusion Criteria and Respondent Demographics:

Inclusion Criteria

 

§    Board-certified or eligible (US only) interventional cardiologists

§    40 from the United States, 20 from Europe

§    In practice between 2 and 30 years

§    Place at least 10 stents per month

 

Purchase this report Reports become free one year after the publication date.

 

> about us      > contact us
© Panel Intelligence, LLC. 1999-2008. All rights reserved.
A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR)
Privacy Policy